Seeking Alpha

MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Cardium Therapeutics, Inc. (CXM) Effects 1-for-20 Reverse Split 0 comments
    Jul 18, 2013 2:11 PM | about stocks: CXM

    Cardium Therapeutics, an asset-based health sciences and regenerative medicine company, announced a 1-for-20 reverse split of the company's issued and outstanding common stock, effective today at market open, reducing the number of issued and outstanding common shares to approximately 6.5 million. The number of authorized shares and the par value per share of common stock will remain unchanged.

    Cardium's common stock will trade under new CUSIP number 141916304, but will maintain its trading symbol, CXM. No fractional shares of common stock will be issued as a result of the reverse stock split and shareholders of record will receive cash in lieu of fractional shares to which they would otherwise be entitled, based upon the price of the company's common stock at close of market July 17, 2013.

    Shareholders who hold their Cardium stock in certificated form will receive correspondence from Computershare Trust Company regarding the exchange of outstanding stock certificates into new certificates or book entry form.

    Cardium said it has filed an amendment to its Restated Articles of Incorporation to effect the reverse stock split, which was authorized by stockholders at the company's annual shareholder meeting earlier this month. The reverse stock split was a condition of the April 2013 securities purchase agreement which was also approved by stockholders at the initial annual meeting of stockholders.

    Cardium anticipates completing the second closing of the remaining 1,656 shares of Series A convertible preferred stock under the registered direct offering for gross proceeds of approximately $1.7 million.

    For more information, visit www.cardiumthx.com

    Please see disclaimer on the MissionIR website
    http://www.missionir.com/disclaimer.html

    Stocks: CXM
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.